Buy BPC-157 10 mg in Australia
BPC-157 10 mg, also written BPC157 or BPC 157, costs $89.99 in Australia from Australian Research Peptides, which supplies laboratories and researchers and has it in stock for same-business-day dispatch when paid before 12pm Sydney time. BPC-157's 10 mg certificate reports 99.635% purity. BPC-157 is a fifteen-amino-acid chain, GEPPPGKPADDAGLV, HPLC-tested, identity-confirmed by mass spectrometry and supplied as freeze-dried white powder sealed in glass and shipped to all states and territories. Its residues match a section of a gastric-juice protein, and laboratory assays describe it binding VEGFR2, a receptor on the cells lining blood vessels. In vitro research purposes only.
Cell Signalling Research · Lyophilised Powder · HPLC-tested · SKU 59095
$89.99
1
Presentation
10 mg per vial
Grade
High-Purity Research Grade
Form
Lyophilised Powder
Category
Cell Signalling Research
Same-day dispatch on business-day orders completed before 12pm Sydney time, Mon–Fri
Tracked shipping Australia-wide ·typically 1–2 business days to most areas by Express Post · free post over $199, free Express over $299
Batch certificates — published in the COA library
For in vitro research purposes only. Not for human consumption. Not for animal consumption. This product is not a drug, food, cosmetic, or dietary supplement. ARP gives no usage, medical or therapeutic guidance of its own.
BPC-157 · 10 mg
$89.99
Browse all Cell Signalling Research
About BPC-157
BPC-157 is studied in angiogenesis and cell-migration research, and every published study on it is preclinical — cell culture and animal work only. The published record stops there, so nothing about the compound is established beyond those model systems. Australian Research Peptides makes no claim about what it does.
BPC-157 is a pentadecapeptide, which simply means a chain of fifteen amino acids. Its sequence, GEPPPGKPADDAGLV, matches a section of a larger protein found in human gastric juice. Four of the fifteen amino acids are proline. Reviews describe the compound as unusually stable in gastric juice, which is uncommon for a peptide. It also appears in the literature as bepecin, PL 14736 and PLD-116. Away from the literature the hyphen tends to disappear, and BPC157 is the same fifteen-amino-acid chain under a different spelling.
Australian Research Peptides supplies BPC-157 on its own, as a single peptide. It appears in two other ARP listings as well, blended with TB-500 and again inside GLOW. The quantity stated here therefore covers the fifteen-amino-acid chain and nothing else. Material sold on this page is a laboratory reference compound for work in glassware and cell culture. It is not intended for people or animals.
BAC water (bacteriostatic water) is also in our range.
The peptide calculator works out the mg/mL concentration of a reconstituted vial.
Content reviewed
Further reading: BPC-157 vs TB-500: What Is the Difference? · Where Is the Best Place to Buy Peptides in Australia?
BPC-157 specifications, storage and shipping
- Compound: BPC-157
- Also known as: BPC-157 (PL 14736, PLD-116)
- Class: Pentadecapeptide; sequence corresponding to a partial fragment of a gastric-juice protein
- Sequence: GEPPPGKPADDAGLV (H-Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val-OH)
- Appearance: White to off-white lyophilised powder
- Sizes & SKUs: 10 mg (59095)
- Presentation: sealed glass vial
- Form: Lyophilised Powder
- Grade: High-purity research grade
- Purity verification: HPLC-assayed to a minimum of 99% purity — the measured result is stated on the published Certificate of Analysis
- Identity confirmation: Mass spectrometry
- Certificates: issued by Janoshik, an independent laboratory, and published in the COA library
- Classification: In vitro research purposes only — laboratory reference material
- Lyophilised — long term
- −20 °C to −80 °C — long-term storage
- Lyophilised — short term
- 2–8 °C — refrigerated, for a few months
- Reconstituted
- 2–8 °C — use within 8–12 weeks
BPC-157 is HPLC-tested for purity and confirmed by mass spectrometry for identity. The full laboratory report is published in the COA library. BPC-157 is tested by Janoshik, an independent laboratory, commissioned by the manufacturer rather than by Australian Research Peptides.
- BPC-157 10 mg: assayed purity 99.635% · measured content 10.93 mg · laboratory batch 2026-06 · analysed 19 June 2026
Business-day orders before 12pm Sydney time are dispatched the same day with tracked shipping. Standard delivery within Australia typically takes 2–5 business days. See Shipping & Delivery for details, and follow your parcel on the Track Order page.
For in vitro research purposes only. Not for human consumption. Not for animal consumption. Not a drug, food, cosmetic, or dietary supplement. No therapeutic or medical claims are made.
Questions about BPC-157
This question guide from Australian Research Peptides covers BPC-157 in Australia: what the listing contains, live buying and delivery questions, research context, handling, testing and comparisons. Start with the quick answers, then open the topic group that matches your search.
Buying, price and availability
Australian Research Peptides supplies BPC-157 within Australia, and a weekday order lodged before 12pm Sydney time leaves the same business day. The listing covers the fifteen-amino-acid chain on its own at one vial strength. Tracked and Express Post delivers to all states and territories.
Whether a BPC-157 order makes the same-day cut-off is decided by when the money is matched rather than when the order is placed, so the payment route matters. PayID typically lands in minutes; a standard bank transfer may not. PayID and bank transfer are the two routes accepted, and every order gets the account details and its reference by email as soon as it is lodged.
A BPC-157 vial comes without a diluent: it holds 10 mg of freeze-dried peptide and nothing else, so the liquid and any measuring equipment are the laboratory's own choice for its method. One vial is normally dissolved once, and the finished solution is best split into portions for storage.
BPC-157 has no approval from the FDA or any comparable agency, and no licensed BPC-157 medicine exists in any country. Its standing under America's pharmacy-compounding rules moved twice during 2026, so anything read about that category is worth checking against the agency itself rather than against a supplier.
Identity, names and exact format
BPC-157 is a synthetic peptide built from fifteen amino acids. It corresponds to part of a protein first isolated from human gastric juice in 1993 (Sikirić 1993). Published work on it uses tendon, bone, gut and blood-vessel tissue models, all of it in animals or cell culture.
The 157 in BPC-157 is a sequence label, not a strength. It identifies this particular fifteen-amino-acid sequence. That sequence is a section of a larger gastric-juice protein rather than a complete protein in itself.
BPC-157 also appears as bepecin, PL 14736 and PLD-116. Chemists also identify its fifteen-amino-acid sequence as GEPPPGKPADDAGLV.
BPC-157 contains fifteen amino acids joined in one chain. That is exactly what the word pentadecapeptide encodes, penta for five and deca for ten. The sequence reads GEPPPGKPADDAGLV, and four of the fifteen are proline. Those residues form part of a larger gastric-juice protein, so BPC-157 is a defined section of a bigger molecule rather than a protein in its own right.
Research context and evidence
BPC157 and BPC-157 are two spellings of one peptide, the fifteen-amino-acid chain GEPPPGKPADDAGLV, so dropping the hyphen changes the typography and nothing else. Australian Research Peptides sells that peptide to researchers and laboratories in Australia as a single 10 mg lyophilised vial, listed once as a single catalogue line. Search boxes, invoices and published papers all vary the spacing, which is why the same compound turns up as bpc 157 and BPC 157 too.
BPC peptide is the shortened form of BPC-157, the fifteen-amino-acid research chain, with its identifying number left off. The phrase reads as a set of initials followed by the word peptide. Australian Research Peptides lists one compound under that shorthand, a single 10 mg freeze-dried vial, and the site's search box resolves the shortened form to the same record.
BPC-157's mechanism is described only in laboratory assays, and it is not settled. Published work associates the peptide with signalling at VEGFR2, a receptor tyrosine kinase (Hsieh 2017), and with the nitric oxide pathway. Reported assay endpoints include FAK and paxillin phosphorylation in cultured fibroblasts (Chang 2011). All of it is preclinical; nothing about the mechanism is established beyond those laboratory systems.
The BPC-157 literature is almost entirely animal and cell-culture work, published across angiogenesis and cell-signalling research over roughly three decades. It is preclinical throughout: the published record stops at cell culture and animal models, and reviews still describe the compound as investigational. Australian Research Peptides supplies it on that basis, as a laboratory reference material rather than a medicine.
Published BPC-157 research consists of preclinical animal and cell-culture studies. The work covers muscle, tendon and bone, the gut, blood vessels and nerve tissue, in surgical animal models and in cells grown in dishes. Reviews still describe BPC-157 as investigational, and the published record establishes no outcome beyond those models.
BPC-157 has been studied in independent laboratories for roughly three decades, but entirely in cell culture and animals. The published record stops at those model systems, so nothing about it is established beyond them. Australian Research Peptides sells it as a research compound and makes no claim that it does anything at all.
Normal, and BPC-157 is the clearest example of it. A fifteen-residue chain dried down to ten milligrams leaves a translucent film clinging to the interior glass instead of a heap of powder, and first-time buyers regularly conclude nothing was supplied. Held sideways under a lamp, the deposit catches light. Diluent settles the question at once, because the film lifts off the wall and goes into solution.
BPC-157 is a tougher peptide than most, but storage still decides how long the material stays intact. Reviews note it survives gastric juice, which few peptides manage. That resilience does not extend to a warm shelf. Keep the sealed vial frozen at -20 °C or colder, dry and away from direct light. Once dissolved, keep the solution cold and out of light, and avoid freezing and thawing it repeatedly.
A BPC-157 vial holds freeze-dried powder and nothing else. There is no diluent inside, no preservative and no second peptide. The diluent is whichever liquid does that dissolving. Add a suitable diluent slowly, aiming the stream at the glass shoulder so it never lands on the cake. Swirl gently until the powder clears, and never shake it. The volume of diluent chosen is what fixes the final strength.
A reconstituted BPC-157 vial is held between 2 and 8 degrees and worked through inside eight weeks to twelve, the condition Australian Research Peptides publishes. The sequence GEPPPGKPADDAGLV sets two aspartates side by side, and aspartate is the amino acid chemists watch most closely once a peptide sits in water. Cysteine, methionine and tryptophan are all absent, so oxidation is not the leading worry.
Handling, storage and measurements
A BPC-157 vial holds 10 mg of peptide and Australian Research Peptides publishes no fill volume for it. Adding more or less diluent changes how concentrated the solution is and nothing about how much peptide is in the glass — the 10 mg is the same either way. The volume is a bench decision rather than something the listing sets.
Two harmless causes cover most cloudy BPC-157 preparations. Air worked into the liquid while mixing reads as cloudiness and disperses on standing, and a vial used straight from cold storage both fogs on the outside and takes up its diluent more slowly. Cloudiness still there after a quarter of an hour, or flecks that will not clear, means the material has not fully dissolved.
BPC-157 is dissolved in an aqueous diluent for laboratory work, chosen by the laboratory to suit its method, because the vial arrives as dry powder with no liquid included. BPC-157 is one plain fifteen-amino-acid chain, carrying no fatty-acid tail and no metal ion, and the volume of diluent added sets the concentration.
The supplier of BPC-157 to laboratories and researchers in Australia is Australian Research Peptides, filing it under Cell Signalling Research as a single-peptide listing separate from the two-peptide blend. The peptide goes through HPLC testing before sale, and the published certificate sits in ARP's CoA library for anyone to read. Vials post domestically by tracked or express service, so no parcel meets a customs desk. The weekday cut-off for same-day dispatch is 12pm Sydney time.
BPC-157 is sold by Australian Research Peptides at one vial strength, so the only lever on cost is how many vials an order carries. Prices are in Australian dollars and come from the current catalogue record rather than being typed into copy. The line is graded HPLC Verified: its published laboratory certificate reports a purity figure measured by HPLC. Postage is charged separately, by the service chosen.
Not on one vial, and not on two — a third BPC-157 vial takes an order past the threshold for free Standard tracked post. A second compound from the range closes the gap as well. Free Express Post sits higher again. Both thresholds are measured by Australian Research Peptides on what the goods came to before any discount was applied.
BPC-157 is sold online only, by Australian Research Peptides, an Australian supplier that posts from within Australia to any address in the country. Money changes hands by PayID or bank transfer, sent from the buyer's own bank rather than keyed into this site. An order reference and the payment details follow by email once the order is lodged.
BPC-157 reaches most Australian addresses in two to five business days on standard tracked post, or one to two on Express Post across the better-served states. Dispatch turns on a 12pm Sydney time cut-off: an order whose payment is matched before that cut-off leaves the same afternoon, and anything after that waits for the next business day. Nothing crosses a border, because Australian Research Peptides posts domestically.
Ordering, payment and Australian delivery
BPC-157 is not approved by the TGA and is not registered for human or veterinary use in Australia. Australian Research Peptides supplies it as a laboratory reference material for in vitro research and makes no medical claim about it. Buyers are responsible for meeting the rules that apply to their own work.
BPC-157 is banned in sport and prohibited at all times, sitting under S0, the non-approved category, because no health regulator anywhere has cleared it for human therapeutic use. Sport Integrity Australia publishes a dedicated substance-education page on it. A therapeutic use exemption is effectively unreachable, since exemptions rest on an approved medical use BPC-157 does not have.
Peptide consignments arriving from abroad can be intercepted in Australia, because unapproved therapeutic goods are among the categories inbound screening looks for, and a detained parcel usually means money gone with nothing received. That exposure does not arise on a BPC-157 order from Australian Research Peptides, which travels only between two Australian addresses. The TGA and Border Force both set out what they screen for.
BPC-157 is tested before Australian Research Peptides supplies it, by an independent laboratory the manufacturer commissions. HPLC measures how pure the material is, and mass spectrometry confirms the measured mass is BPC-157's. Identity carries the most weight with BPC-157. A chain a few amino acids too long or short shares nearly all the same sequence, and only the mass separates them. A matching certificate is currently published for this product and strength. Open the 10 mg certificate.
Access and regulatory questions
The only real check on BPC-157 is third-party HPLC analysis tied to the batch you received. Australian Research Peptides publishes its certificates in a COA library that names the product and strength each one covers, readable before you order rather than on request afterwards. A supplier who will not show you a batch-matched certificate has not given you evidence.
BPC-157 and TB-500 are studied in overlapping repair contexts but by different mechanisms — BPC-157 through angiogenic and growth-factor pathways, TB-500 as a fragment of thymosin beta-4 acting on actin. BPC-157 has the larger and older animal literature, particularly for gut and tendon models. Australian Research Peptides also lists the two together as a single blended vial if the choice is not obvious.
Australian Research Peptides’ standalone BPC-157 line supplies the peptide on its own, with no second peptide in the vial. The blend puts BPC-157 and TB-500 together as one freeze-dried powder, so the quantity printed on the blend is the combined total for both. The two are separate listings with separate stock records. Neither substitutes for the other.
They are. Australian Research Peptides lists the pair pre-blended in one vial and again inside GLOW and KLOW. The two are structurally unrelated — BPC-157 is a fifteen-amino-acid chain, TB-500 a seven-amino-acid piece of thymosin beta-4 that grips actin, the fibres a cell uses to hold its shape — and each is also listed on its own. Every blend is independently lab-tested before sale.
Australian Research Peptides supplies BPC-157; Chemist Warehouse does not, and neither does any other Australian pharmacy. The peptide has no marketing authorisation here, which is the thing a pharmacy would need before it could put a product on a shelf. ARP lists it as a 10 mg lyophilised research vial rather than as a consumer product.